Husk Fiber Intervention on Metabolic Health of Centrally Obese School Teachers

NCT06188728 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2024-01-05

No results posted yet for this study

Summary

A group of 120 school teachers (male=60, female=60) was divided into four subgroups for sixteen weeks of an interventional study. One group was kept in control while the other three groups were assigned intervention. One group was assigned intervention of lifestyle modification (LSM), the other group assigned the intervention of 5 gm psyllium husk fiber (PSH) two times a day, and the third group assigned the combined intervention of LSM \& PSH. Each group comprised of 30 subjects with equal gender bifurcation (15 male and 15 female).

Conditions

  • Metabolic Disease

Interventions

DIETARY_SUPPLEMENT

effect of 10 gm psyllium husk fiber twice a day, 30 minutes before breakfast and dinner

comparing the effect of psyllium husk fiber and lifestyle modification alone with the combined effect of psyllium husk fiber on metabolic health of centrally obese school teachers

BEHAVIORAL

Effect of life style modification (Diet, Behavior and physical activity)

To assess the effect of life style modification (Diet, Behavior and physical activity) on centrally obese school teachers

COMBINATION_PRODUCT

Combined effect of 10 gm Psyllium husk fiber and lifestyle modification

To evaluate the combined effect of 10 gm psyllium husk fiber in gel form, 30 minutes before breakfast and dinner along with dietary, behavioral and physical activity modification on centrally obese school teachers

OTHER

Control

No intervention

Sponsors & Collaborators

  • University of Agriculture, Peshawar

    collaborator OTHER
  • University of Peshawar

    lead OTHER

Principal Investigators

  • Zia Din, PhD · Chairman department of human Nutrition

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-09-07
Primary Completion
2021-05-27
Completion
2021-07-30

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06188728 on ClinicalTrials.gov